uniQure (QURE) Acquisitions (2022)

uniQure (QURE) recorded quarterly Acquisitions of $1.1 million in Q3 2022, up 31.14% quarter-over-quarter from $822000.0 in Q1 2022.

uniQure (QURE) Acquisitions (2022) Analysis & Trends

uniQure's Acquisitions history runs 1 years deep, the most recent figure standing at $1.1 million for Q3 2022.

  • In Q3 2022, Acquisitions changed N/A year-over-year to $1.1 million; the TTM figure through Dec 2022 stood at $1.9 million (changed N/A YoY), while the FY2022 annual figure was $1.9 million, down 96.2% from the prior year.
  • Acquisitions was $1.1 million for Q3 2022 at uniQure, up from $822000.0 in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $1.1 million in Q3 2022 to a low of $822000.0 in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 uniQure 2.88 Bn 2.88 Bn 3.34 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2022 1.08 Mn
Mar 31, 2022 822,000.00